Recent Updates
Recently added Catalysts
RARE

Ultragenyx Announces In-Licensing of Clinical-Stage Product Triheptanoin

Thursday, January 10, 2013 1 min read
Key Takeaway: Ultragenyx Announces In-Licensing of Clinical-Stage Product Triheptanoin

Full Press Release Details

Ultragenyx Announces In-Licensing of Clinical-Stage Product Triheptanoin.
Tags: RARE Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jan 10, 2013